Skip to main content
Premium Trial:

Request an Annual Quote

DSM Licenses Phylosopher, Expressionist Software from Genedata

NEW YORK, July 28 (GenomeWeb News) - DSM has taken a license to Genedata's gene-function and pathway-analysis tool Phylosopher and its Expressionist microarray data-analysis tool, Basel, Switzerland-based Genedata said today.

 

Under the worldwide license, Genedata's products will be deployed at DSM's major research sites and will be used for all biological research, in particular metabolic engineering projects.

 

DSM, based in the Netherlands, develops and sells products for human and animal nutrition and health, cosmetics, pharmaceuticals, automobile products, coatings, electrics and electronics, and products for the construction industry. The company has approximately 24,000 employees worldwide.

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.